U.S., March 5 -- ClinicalTrials.gov registry received information related to the study (NCT07450443) titled 'Role of the Gut Vascular Barrier and Microbiota in Autism Spectrum Disorders' on Jan. 19.
Brief Summary: Recent research links gut microbiota alterations to Autism Spectrum Disorders (ASD), a neurobiological condition with multifactorial bases. In some ASD patients, altered gut flora and increased intestinal permeability are observed, influencing the central nervous system's development and function. Chronic gastrointestinal (GI) symptoms are commonly associated with ASD and correlate with its severity. This non-pharmacological interventional clinical study aims to investigate the role of gut microbiota on ASD and the effectiveness ...